Revolution Medicines price target raised to $320 from $230 at Evercore ISI
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Evercore ISI raises RVMD target to $320 from $230; current price $215.44.
Target: $320
Posted price: $215.44
Analyst firm: Evercore ISI
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.